28m to scientists + 10m to directors = 38m which was roughly the pre-Opes Solamind holdingsAt least the directors are paying 50c for their shares rather than nothing
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor